Consultations Archive

NHS England is engaging stakeholders over its 2023 finance and payment arrangements and schemes. Their survey seeks feedback on the policies being considered for the NHS payment scheme that is expected to come into effect from 1 April 2023. It accompanies the series of finance and payment engagement workshops and webinars running during July 2023. Please note the survey closes…

NICE is welcoming commentary on draft guidelines regarding the assessment and management of Thyroid Cancer. This guideline is for healthcare professionals in primary, secondary and tertiary care, commissioners and providers of services for people with thyroid cancer, people with suspected and confirmed thyroid cancer, their families and carers, and the public. The consultation closes at 5pm on Thursday 4 August…

MHRA utilise expert advisory committees to provide additional support and knowledge in areas that need this, including for specific medical devices and spanning types of medicines. These expert groups have a code of practice that those involved are obliged to follow, and this code of practice is now up for review. The proposed changes are suggesting more involvement from patients…

HMRC and HMT are running a consultation titled: Call for evidence: An Independent Customs Regime. As part of this, they welcome views on how we can improve the UK’s customs system by simplifying processes for traders and embracing innovation. This call for evidence invites respondents’ views on the customs intermediary sector, the Simplified Customs Declaration Process (SCDP), and the Transit…

The public consultation on draft guidance recommendations for the NICE medical technology evaluation of the GID-MT566 Faecal microbiota transplant for recurrent Clostridioides difficile infection is now open and closes on 11th May 2022 at 5:00pm. Comments on the consultation document are invited from anyone who has an interest in the technology, the clinical area, or both. All documents relating to…

The BIVDA response to the 10-Year Cancer Plan Call for Evidence was submitted on 31 March 2022. Please find here the full response. Thank you to those member companies who provided input into this draft.